Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease

Medical Hypotheses

Volumn 65, Issue 6, 2005, Pages 1106-1119

  Schmitt, H Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 2 RECEPTOR;

ALZHEIMER DISEASE; AROUSAL; ATTENTION; CELL CYCLE; CHOLINERGIC SYSTEM; COGNITION; DEMENTIA; FOREBRAIN; GABAERGIC TRANSMISSION; HUMAN; HYPOTHESIS; LEARNING; MEMORY; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE DEGENERATION; NERVE EXCITABILITY; NEUROMODULATION; NEUROPATHY; NONHUMAN; NORADRENERGIC SYSTEM; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; THEORY;

EID: 26444549328     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.06.018     Document Type: Article

References (150)

1. A. Adunsky, D. Baram, M. Hershkowitz, and Y.A. Mekori Increased cytosolic free calcium in lymphocytes of Alzheimer patients J Neuroimmunol 33 1991 167 172
2. N. Agell, R. Aligue, V. Alemany, A. Castro, M. Jaine, and M.J. Pujol New nuclear functions for calmodulin Cell Calcium 23 1998 115 121
3. B.W. Agranoff, J.A. Benjamins, and A.K. Hajra Lipids G.J. Siegel B.W. Agranoff R.W. Albers S.K. Fisher M.D. Uhler Neurochemistry 6th ed Molecular, cellular and medical aspects 1999 Lippincott-Raven Philadelphia, NJ 47 67
4. M.S. Airaksinen, S. Alanen, S. Szabat, T.J. Visser, and P. Panula Multiple neurotransmitters in the tuberomammilary nucleus: comparison of rat, mouse, and guinean pig J Comp Neurol 323 1992 103 116
5. B.C. Albensi, C. Igoechi, D. Janigro, and E. Ilkanide Why do many NMDA antagonists fail while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury Am J Alzheimer's Dis Other Demen 19 2004 269 274
6. M. Alkondon, E.F. Pereira, H.M. Eisenberg, and E.X. Albuquerque Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks J Neurosci 20 2000 66 75
7. T.G. Allen, and D.A. Brown Detection and modulation of acetylcholine release from neurites of rat basal forebrain cells in culture J Physiol Lond 492 Pt2 1996 453 466
8. R. Aloyz, J.P. Fawset, D.R. Kaplan, R.A. Murphey, and F.D. Miller Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS Learn Mem 6 1999 216 231
9. A. Alzheimer Über eigenartige Krankheitsfälle des späteren Alters Z ges Neurol Psychiat 4 1911 356 385
10. R. Andrade Regulation of membrane excitability in the central nervous system by serotonin receptor subtypes Ann NY Acad Sci 861 1998 190 203
11. H. Arita, K. Ichikawa, and M. Sakamoto Serotonergic cells in nucleus raphe pallidus provide tonic drive to posterior cricoarythenoid motor neurons via 5-hydroxytryptamine2 receptors in rat Neurosci Lett 197 1995 113 116
12. C. Asanuma Distribution of neuromodular inputs in the reticular and dorsal thalamic nuclei M. Steriade E.G. Jones D.A. McCormick Thalamus Experimental and clinical aspects vol. II 1997 Elsevier Amsterdam 93 153 [chapter 4]
13. G. Aston-Jones, J. Rajkowski, P. Kubiac, R.J. Valentino, and M.T. Shipley Role of the locus coeruleus in emmotional activation Progr Brain Res 107 1996 379 402
14. C.S. Atwood, G.M. Bishop, G. Perry, and M.A. Smith Amyloid-β: A vascular sealant that protects against hemorrhage J Neurosci 70 2002 356
15. B.J. Balin, H.C. Gérard, E.J. Arking, D.M. Appelt, P.J. Branigan, and J.T. Abrams Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain Med Microbiol Immunol 187 1998 23 42
16. J. Barg, M. Belcheva, J. Rowinski, A. Ho, W.J. Burke, and H.D. Chung Opioid receptor density changes in Alzheimer amygdala and putamen Brain Res 632 1993 209 215
17. M.F. Beal Oxidative metabolism Ann NY Acad Sci 924 2000 164 169
18. M.F. Beal, M.F. Mazurek, V.T. Tran, G. Chatta, E.D. Bird, and J.B. Martin Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease Science 229 1985 289 291
19. I. Bechmann, and R. Nitsch Involvement of non-neuronal cells in entorhinal-hippocampal reorganization following lesions Ann NY Acad Sci 911 2000 192 206
20. B receptors: drugs meet clones Curr Opin Neurobiol 8 1998 345 350
21. J.P. Blass The mitochondrial spiral: An adequate cause of dementia in the Alzheimer's syndrome Ann NY Acad Sci 924 2000 170 183
22. P. Blier, G. Pineiro, M. el Mansari, R. Bergeron, and C. de Montigny Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission Ann NY Acad Sci 861 1998 204 216
23. W. Bondareff, C. Mountjoy, M. Roth, M.N. Rossor, and L.L. Iversen Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease Alzheimer Dis Assoc Disord 1 1987 256 262
24. H. Braak, and E. Braak Alzheimer's disease affects limbic nuclei of the thalamus Acta Neuropathol (Berl) 81 1991 261 268
25. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol (Berl) 82 1991 239 259
26. H. Braak, and E. Braak Anatomy of the human hypothalamus (chiasmatic and tuberal region) Prog Brain Res 93 1992 3 18
27. A. von Braunmühl Alzheimersche Krankheit O. Lubarsch F. Henke R. Rössle W. Scholz Handbuch der speziellen pathologischen Anatomie und Histologie vol. XIII/1A 1957 Springer Berlin, Göttingen, Heidelberg 123 132
28. M.C. Buhot, S. Martin, and L. Segu Role of serotonin in memory impairment Ann Med 32 2000 210 221
29. 2 neuronal nicotinic acetylcholine receptor Mol Pharmacol 53 1998 555 563
30. G. Buzsáki, G. Dragoi, J. Csicsvari, H. Hirase, A. Czurko, and D.A. Henze GABAergic interneuronal networks in the hippocampus D.L. Martin R.W. Olsen GABA in the nervous system. The view at fifty years 2000 Lippincott Williams & Wilkins Philadelphia, PA 317 336
31. L.F. Callado, and J.A. Stamford Alpha2A- but not alpha2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data Eur J Pharmacol 366 1999 35 39
32. 4 receptors in rat basal ganglia and hippocampus Eur J Neurosci 8 1996 2591 2598
33. M.L. Cotrina, and M. Nedergaard Intracellular calcium control mechanisms in glia H. Kettenmann B.R. Ransom Neuroglia 2nd ed 2005 Oxford University Press Oxford, New York 229 239
34. R.F. Cowburn, C.J. Fowler, and C. O'Neill Neurotransmitter receptor/G-protein mediated signal transduction in Alzheimer's disease brain Neurodegeneration 5 1996 483 488
35. U. De Boni, and D.R. Crapper Paired helical filaments of the Alzheimer-type in cultured neurones Nature 271 1978 566 568
36. J.D. Dubreuil Enterotoxigenic Escherichia coli heat-stable toxins J.E. Alouf J.H. Freer The comprehensive sourcebook of bacterial protein toxins 2nd ed 1999 Academic Press London, San Diego 525 544
37. 35S]GTPγ S-binding responses in the human and monkey brain Eur J Neurosci 11 1999 1809 1817
38. 3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa Brain Res 676 1995 336 342
39. D.W. Ellison, M.F. Beal, M.F. Mazurek, E.D. Bird, and J.B. Martin A postmortem study of amino acid neurotransmitters in Alzheimer's diasease Ann Neurol 20 1986 616 621
40. N.B. Farber, J.W. Newcomer, and J.W. Olney The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease Prog Brain Res 116 1998 421 437
41. D. Ferster, and K.D. Miller Neural mechanisms of orientation selectivity in the visual cortex Annu Rev Neurosci 23 2000 441 471
42. S.K. Fisher, and B.W. Agranoff Phosphoinositides G.J. Siegel B.W. Agranoff R.W. Albers S.K. Fisher M.D. Uhler Neurochemistry 6th ed Molecular, cellular and medical aspects 1999 Lippincott-Raven Philadelphia, NJ 415 431
43. M. Freistadt Distribution of the polio-virus receptor in human tissue E. Wimmer Cellular receptors for animal viruses 1994 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York 445 461
44. M. Garcia-Alloza, W.D. Hirst, C.P. Chen, B. Lasheras, P.T. Francis, and M.J. Ramirez Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease Neuropsychopharmacology 29 2004 410 416
45. J.W. Geddes, Z. Peng, and D.H. Wiley Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism. Implications for Alzheimer disease Mol Chem Neuropathol 1996 65 74
46. M. Goedert Tau protein and the neurofibrillary pathology of Alzheimer's disease Ann NY Acad Sci 777 1996 121 131
47. P.E. Granum, and S. Brynestad Bacterial toxins as food poisons J.E. Alouf J.H. Freer The comprehensive sourcebook of bacterial protein toxins 2nd ed 1999 Academic Press London, San Diego 669 681
48. J.Z. Guo, T.L. Fredway, and V.A. Chiappianelli Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus J Neurosci 18 1998 1963 1969
49. H.L. Haas Amine neurotransmitter action in the hippocampus W. Seifert Neurobiology of the hippocampus 1983 Academic Press London, New York 139 151
50. H. Häfner The brain disease of aging - Epidemiology and risk factors of senile dementia (Alzheimer) K. Beyreuther G. Schettler Molecular mechanisms of aging 1990 Springer Berlin, Heidelberg, New York 2 17
51. J. Hardy, and D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol Sci (TIPS) 12 1991 383 388
52. W.J. Hoogendijk, M.G. Feenstra, M.H. Botterblom, J. Gilhuis, I.E. Sommer, and W. Kamphorst Increased activity of surviving locus ceruleus neurons in Alzheimer's disease Ann Neurol 45 1999 82 91
53. S. Hoyer Changes in brain energy metabolism and the early detection of Alzheimer's disease P. Dostert P. Riederer M. Strolin-Benedetti R. Robucci Early markers in Parkinson's and Alzheimer's disease New vistas in drug research vol. 1 1990 Springer Wien 233 244
54. P. Hughes, and M. Dragunow Activation of pirencepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons Brain Res Mol Brain Res 24 1994 166 178
55. 125I]galanin binding sites despite loss of cholinergic neurones of the hippocampus in Alzheimer's disease Brain Res 568 1991 303 306
56. K. Iqbal, and I. Grundke-Iqbal Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies Acta Neuropathol 109 2005 25 31
57. I. Iraizoz, J.L. Guijarro, L.M. Gonzalo, and S. de Lacalle Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia Acta Neuropathol 98 1999 186 196
58. B.L. Jacobs, and C.A. Fornal Serotonin and behavior. A general hypothesis F.E. Bloom D.J. Kupfer Psychopharmacology: The fourth generation of progress 1995 Raven Press New York 461 469
59. K.A. Jellinger, and C. Bancher Senile dementia with tangles Brain Pathol 8 1998 367 376
60. 2-adrenergic receptors in cerebral microvessels in Alzheimer disease Neurosci Lett 106 1889 233 238
61. 2-receptors in prefrontal cortex and hippocampus J Neurochem 53 1989 1772 1781
62. E.R. Kandel The molecular biology of memory storage: A dialog between genes and synapses Biosci Rep 21 2001 565 611
63. E. Kandel, and T. Abel Neuropeptides, adenylyl cyclase and memory Science 268 1995 825 826
64. S. Kastner, and L.G. Ungerleider Mechanism of visual attention in the human cortex Annu Rev Neurosci 23 2000 315 341
65. H. Kettenmann, and C. Steinhäuser Receptors for neurotransmitters and hormones H. Kettenmann B.R. Ransom Neuroglia 2nd ed 2005 Oxford University Press Oxford, New York 131 145
66. Z.S. Khachaturian Calcium hypothesis of Alzheimer's disease and brain aging Ann NY Acad Sci 747 1994 1 11
67. A. Kolta, R. Dubuc, and J.P. Lund An immunocytochemical and autoradiographic investigation of the serotoninergic innervation of trigeminal mesencephalic and motor nuclei in the rabbit Neuroscience 53 1993 1113 1126
68. T.M. Korotkova, H.L. Haas, and R.E. Brown Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro Neurosci Lett 320 2002 133 136
69. T. Kubo, A. Maeda, K. Sugimoto, I. Akida, A. Mikami, and H. Takahashi Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence FEBS Lett 209 1989 367 373
70. J.S. Lacroix, A.M. Kurth, S. Auberson, and C. Bretton β-Adrenergic mechanisms in the nasal mucosa vascular bed Eur Arch Otorhinolaryngol 252 1995 298 303
71. F. LaFerla Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease Nature Rev Neurosci 3 2002 862 872
72. 2A receptors in the postmortem temporal cortex correlates with the rate of cognitive decline in Alzheimer's disease Psychopharmacology 179 2005 673 677
73. T.L. Lentz Rabies virus binding to an acetylcholine receptor α-subunit peptide J Mol Recognit 3 1990 82 88
74. J. Lindström Nicotinic acetylcholine receptors in health and disease Mol Neurobiol 15 1997 193 222
75. C. Lüscher, R.A. Nicoll, R.C. Malenka, and D. Muller Synaptic plasticity and dynamic modulation of the postsynaptic membrane Nature Neurosci 3 2000 545 550
76. G. Lynch Memory consolidation and long-term potentiation M.S. Grazzaniga The new cognitive neurosciences 2nd ed 2000 MIT Press Cambridge, MA 139 157
77. D.M.A. Mann, P.O. Yates, and B. Marcyniuk Dopaminergic neurotrandmittersystems in Alzheimer's disease and Down's syndrome at middle age J Neurol Neurosurg Psychiat 50 1987 341 344
78. L. Manuelidis, G. Murdoch, and E.E. Manuelidis Potential involvement of retroviral elements in human dementias CIBA Found Sympos 135 1988 117 134
79. 2+ ions in their function and desensitization Neurochem Int 34 1999 319 328
80. R.T. Marrocco, and M.C. Davidson Neurochemistry of attention R. Parasuraman The attentive brain 1998 MIT Press Cambridge, MA 35 50
81. J.C. Martel, R. Alagar, Y. Robitaille, and R. Quirion Neuropeptide Y receptor binding sites in human brain. Possible alterations in Alzheimer's disease Brain Res 519 1990 228 235
82. 3H]epibatidine Brain Res 801 1998 143 149
83. E. Masliah, M. Ellisman, B. Carragher, M. Mallory, S. Yuong, and L. Hanson Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer's disease J Neuropathol Exp Neurol 51 1992 404 414
84. C. Masters, and K. Beyreuther Science, medicine, and the future: Alzheimer's disease Brit Med J 316 2002 446 448
85. M.P. Mattson Calcium and neuronal injury in Alzheimer's disease. Contributions of β-amyloid precursor protein metabolism, free radicals, and metabolic compromise Ann NY Acad Sci 747 1994 50 76
86. M.P. Mattson, and K. Furukawa Dysregulation of calcium signaling in Alzheimer's pathogenesis: Impact on neuronal synaptic plasticity and cell death, neurogenesis, and glial functions K. Iqbal B. Winblad Alzheimer's disease and related disorders: Research advances 2003 "Ana Aslan" Internat Acad Aging Bucharest, Romania 433 443
87. A. Mayerhofer, N. Dimitrijevic, and L. Kunz The expression and biological role of the non-neuronal cholinergic system in the ovary Life Sci 72 2003 2039 2045
88. J.J. Meana, F. Barturan, M.A. Garro, J.A. Garcia-Sevilla, and A. Fontan Decreased density of presynaptic α2-adrenoceptors in postmortem brains of patients with Alzheimer's disease J Neurochem 58 1992 1896 1904
89. W. Meier-Ruge, and C. Bertoni-Feddari The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease Rev Neurosci 7 1996 1 19
90. Y. Meng, H. Xu, R. Wang, Z. Ji, S. Yu, and J. Zhou Impairment of signal transduction pathway on neuronal survival in brains of Alzheimer's disease Zhonghua Bing Li Xue Za Zhi 31 2002 502 505
91. 1C receptor mRNA in rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution Neuroscience 35 1990 577 591
92. M.-M. Mesulam Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain F.E. Bloom D.J. Kupfer Psychopharmacology: The fourth generation of progress 1995 Raven Press New York 135 146
93. A.K. Mohammed, O.O. Magnusson, F. Fonnum, E. Norrby, M. Schultzberg, and K. Kristenson Behavioral deficits and serotonin depletion in adult rats after transient infant nasal viral infection Neuroscience 35 1990 355 363
94. H.C. Moises, B.D. Waterhouse, and D.J. Woodward Locus coeruleus stimulation potentiates local inhibitory processes in rat cerebellum Brain Res Bull 10 1983 795 804
95. S.P. Neeley, A.J. Cross, T.J. Crow, J.A. Johnson, and G.R. Taylor Herpes simplex virus encephalitis. Neuroanatomical and neurochemical selectivity J Neurol Sci 71 1985 325 337
96. E.A. Newman New roles for astrocytes: regulation of synaptic transmission Trends Neurosci 26 2003 536 542
97. E.A. Newman Glia and synaptic transmission H. Kettenmann B.R. Ransom Neuroglia 2nd ed 2005 Oxford University Press Oxford, New York 131 145
98. 2c receptors stimulate amyloid precursor protein ectodomain secretion J Biol Chem 271 1996 4188 4194
99. R.A. Nixon Calcium-activated neurtral proteinases as regulators of cellular function Ann NY Acad Sci 568 1989 198 208
100. A. Nordberg Neuroreceptor changes in Alzheimer disease Cerebrovasc Brain Metab Rev 4 1992 303 328
101. A. Nordberg, I. Alafuzoff, and B. Winblad Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia J Neurosci Res 31 1992 103 111
102. D. Oliver, J. Ludwig, E. Reisinger, W. Toellner, J.P. Ruppersberg, and B. Fakler Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells Mol Pharmacol 60 2001 183 189
103. J.M. Palacios, G. Mengod, D. Hoyer, C. Waeber, M. Pompeiano, and S. Nicolou Autoradiographic localization of 5-HT receptor subtypes P.B. Bradley S.L. Handley S.J. Cooper B.J. Key N.M. Barnes J.H. Coote Serotonin, CNS receptors and brain function Advances in the biosciences vol. 85 1992 Pergamon Press Oxford, New York 61 72
104. A.M. Palmer Neurochemical studies of Alzheimer's disease Neurodegeneration 5 1996 381 391
105. A.M. Palmer, P.T. Francis, D.M. Bowen, D. Neary, D.M.A. Mann, and J.S. Snowden Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease Brain Res 414 1987 365 375
106. F. Paoletti, A. Mocali, and D. Tombaccini Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts J Cell Physiol 172 1997 63 68
107. R. Parasuraman, and P.M. Greenwood Selective attention in aging and dementia R. Parasuraman The attentive brain 1998 MIT Press Cambridge, MA 461 487
108. A. Pazos, A. Probst, and J.M. Palacios β-Adrenoceptor subtypes in the human brain Brain Res 358 1985 324 328
109. A. Pazos, A. Probst, and J.M. Palacios Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors Neuroscience 21 1987 123 139
110. 3H]Minaserin: differential lacking of serotonin and histamine receptors in rat brain J Pharmacol Exp Ther 216 1981 142 148
111. G. Perry, R.J. Castellani, M.A. Smith, P.L.R. Harris, Z. Kubat, and K. Ghanbari Oxidative damage in the olfactory system in Alzheimer's disease Acta Neuropathol 106 2003 552 556
112. R.H. Perry, J.M. Candy, E.K. Perry, D. Irving, G. Blessed, and A.F. Fairbairn Extensive cell loss of choline acetyl transferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease Neurosci Lett 33 1982 311 315
113. W.A. Phillips Theories of cortical computation M.D. Rugg Cognitive neuroscience 1997 Psychology Press Hove, East Sussex, UK 11 46
114. H. Pollard, and M.L. Bouthenet Autoradiographic visualization of the three histamine receptor subtypes in the brain J.-.C. Schwartz H.L. Haas The histamine receptor. Receptor biochemistry and methodology 1992 Wiley-Liss New York 179 192
115. D.L. Price Aging of the brain and dementia of the Alzheimer type E.R. Kandel J.H. Schwartz T.M. Jessell Principles of neural science 4th ed 2000 McGraw-Hill New York 1149 1187
116. H.W. Querfurth, and D.J. Selkoe Calcium ionophor increases amyloid beta peptide production by cultured cells Biochemistry 33 1994 4550 4561
117. S.J. Rapoport Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation Ann NY Acad Sci 893 1999 138 153
118. B. Reisberg, R. Doody, A. Stöffler, F. Schmitt, S. Ferris, and H.J. Möbius Memantine in moderate-to-severe Alzheimer's disease New Engl J Med 348 2003 1333 1341
119. U. Ribary, A.A. Ioannides, K.D. Singh, R. Hasson, J.P. Bolton, and F. Lado Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans Proc Natl Acad Sci USA 88 1991 11037 11041
120. P. Riederer, E. Sofie, G. Moll, Wichart I. Freyberger, W. Gsell, and K. Jellinger Senile dementia of Alzheimer's type and Parkinson's disease: neurochemical overlaps and specific differences P. Dostert P. Riederer M. Strolin Benedetti R. Ronoucci Early markers in Parkinson's and Alzheimer's disease New vistas in drug research vol. 1 1990 Springer Wien, New York 221 223
121. T.W. Robbins Arousal and attention: Psychopharmacological and neuropsychological studies in experimental animals R. Parasuraman The attentive brain 1998 MIT Press Cambridge, MA 189 220
122. M.A. Rogawski What is the rationale for new treatment strategies in Alzheimer's disease? CNS Spectr 9 Suppl. 5 2004 6 12
123. U. Rüb, K. Del Tredici, C. Schultz, D.R. Thal, E. Braak, and H. Braak The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei Neuropathol Appl Neurobiol 26 2000 553 567
124. S.W. Scheff, S.T. DeKosky, and D.A. Price Quantitative assessment of cortical synaptic density in Alzheimer's disease Neurobiol Aging 11 1990 29 37
125. H.P. Schmitt DVL, a conserved aspartate, valine, leucine motif in amyloid precursor protein (APP) and affected modulatory amine transmitter receptors: might it be a pivotal target of molecular assault in Alzheimer disease? Neurobiol Aging 23 2002 1S:S373 (Abst)
126. H.P. Schmitt On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease Med Hypoth 65 2005 259 265
127. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
128. T.R. Soderling, and V.A. Derkach Postsynaptic protein phosphorylation and LTP (TINS) Trends Neurosci 23 2000 75 80
129. E. Sontag, A. Luangpirom, C. Hladik, I. Mudrak, E. Ogris, and S. Speciale Altered expression levels of the protein phosphatase 2A ABα C enzyme are associated with Alzheimer disease pathology J Neuropathol Exp Neurol 63 2004 287 301
130. V. Soontornniyomkij, G. Wang, C.A. Pittman, R.L. Hamilton, C.A. Wiley, and C.L. Achim Absence of brain-derived neurotrophic factor and trkB receptor immunoreactivity in glia of Alzheimer's disease Acta Neuropathol 98 1999 345 348
131. 2A adrenergic receptors Invest Ophthalmol Vis 37 1996 2426 2433
132. M. Steriade E.G. Jones D.A. McCormick Thalamus. Organization and function vol. I 1997 Elsevier Amsterdam
133. 3 receptor mRNA Proc Natl Acad Sci USA 90 1993 1430 1434
134. R.D. Terry, L.A. Hansen, R. DeTheresa, P. Davies, H. Tobias, and R. Katzman Senile dementia of Alzheimer type without neocortical neurofibrillary tangles J Neuropathol Exp Neurol 46 1987 262 268
135. L.M. Tolbert, D.S. Russell, and R.S. Duman Norepinephrine activates extracellular-regulated kinase in cortical neurons Biol Psychiat 54 2003 983 993
136. R.D. Traub, J.G. Jefferys, and J.G.R. Whittington Fast oscillations in cortical circuits 1999 MIT Press Cambridge, MA p. 1-324
137. E.M. Ullian, S.K. Sapperstein, K.S. Christopherson, and B.A. Barres Control of synapse number by glia Science 291 2001 657 661
138. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex J Neurosci 17 1997 2785 2795
139. G.W. Van Hoesen Cortical feedforward and cortical feedback neural systems in Alzheimer's disease B.T. Hyman C. Duyckaerts Y. Christen Connections, cognition, and Alzheimer's disease 1997 Springer Berlin, Heidelberg, New York 17 31
140. 2+-induced apoptosis through calcineurin dephosphorylation of BAD Science 284 1999 339 343
141. B.D. Waterhouse, F.M. Sessler, W. Liu, and C.-S. Lin Second messenger-mediated actions of norepinephrine on target neurons in central circuits: a new perspective on intracellular mechanisms and functional consequences Prog Brain Res 88 1991 351 362
142. M.J. Webster, and L.G. Ungerleider Neuroanatomy of visual attention R. Parasuraman The attentive brain 1998 MIT Press Cambridge, MA 19 34
143. H.T. Weiler, R.U. Hasenohrl, A.A. van Landeghem, J. Brankack, J.P. Houston, and H.L. Haas Differential modulation of hippocampal signal transfer by tuberomammillary nucleus stimulation in freely moving rats dependent on behavioral state Synapse 28 1998 294 301
144. H.M. Wisniewski, R.C. Moretz, and A.S. Lossinski Evidence for induction of localized amyloid and neuritic plaques by an infectious agent Ann Neurol 10 1981 517 522
145. 4 receptors in brain tissues from patients with neurodegenerative disorders Behav Brain Res 73 1996 249 252
146. Y. Yang, K. Beyreuther, and H.P. Schmitt Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary degenerative and vascular dementia: A comparative immunocytochemical and quantitative study using a graph method Analyt Cell Pathol 19 1999 125 138
147. Y. Yang, E.J. Mufson, and K. Herrup Neuronal cell death is preceded by cell cycle events at all stages Alzheimer's disease J Neurosci 23 2003 2557 2563
148. C.M. Yates, J. Butterworth, M.C. Tennant, and A. Gordon Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias J Neurochem 55 1990 1624 1630
149. L. Záborszky, W.E. Cullinan, and V.N. Luine Catecholaminergic- cholinergic interaction in the basal forebrain Prog Brain Res 98 1993 31 49
150. L. Záborszky, K. Pang, J. Somogyi, Z. Nadasdy, and I. Kallo The basal forebrain corticopetal system revisited Ann NY Acad Sci 877 1999 339 367